GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics

As several Indian pharma giants race to launch cheaper generics for Semaglutide, the active ingredient in popular weight-loss drugs Ozempic and Wegovy, international brokerage Jefferies said that Sun Pharma, Lupin and Torrent Pharma can emerge as the eventual winners.Novo Nordisk’s patent for GLP-1 (glucagon-like peptide-1) therapy expired last week. Jefferies in its latest report said that after the patent expiry, more than 10 brands have launched their versions online, and over 40 brands are e...